volibris
glaxosmithkline (ireland) limited - ambrisentaania - hypertensio, keuhkokuume - verenpainelääkkeet, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.
zinforo
pfizer ireland pharmaceuticals - keftaroliinifosamiili - community-acquired infections; skin diseases, infectious; pneumonia - systeemiset bakteerilääkkeet, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
spinraza
biogen netherlands b.v. - nusinersen natriumia - lihassärky, spinaali - muut hermoston huumeet - spinraza on tarkoitettu 5q spinal lihasatrofian hoitoon.
engerix-b 20 mikrog/ml injektioneste, suspensio
glaxosmithkline biologicals sa - hepatiitti b-virus, pinta-antigeeni, rdna - injektioneste, suspensio - 20 mikrog/ml - hepatiitti b
sertralin teva 50 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - sertralini hydrochloridum - tabletti, kalvopäällysteinen - 50 mg - sertraliini
sertralin teva 100 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - sertralini hydrochloridum - tabletti, kalvopäällysteinen - 100 mg - sertraliini
abacavir/lamivudine teva 600 mg / 300 mg tabletti, kalvopäällysteinen
teva b.v. - lamivudine, abacavir - tabletti, kalvopäällysteinen - 600 mg / 300 mg - lamivudiini ja abakaviiri
bortezomib teva 3.5 mg injektiokuiva-aine, liuosta varten
teva b.v. - bortezomibum - injektiokuiva-aine, liuosta varten - 3.5 mg - bortetsomibi
bortezomib teva 2.5 mg injektiokuiva-aine, liuosta varten
teva b.v. - bortezomibum - injektiokuiva-aine, liuosta varten - 2.5 mg - bortetsomibi
bortezomib ebewe 3.5 mg injektiokuiva-aine, liuosta varten
ebewe pharma ges.m.b.h. nfg.kg - bortezomibum - injektiokuiva-aine, liuosta varten - 3.5 mg - bortetsomibi